BrainStorm Granted Patents for Allogeneic Exosome Platform-Product in Neurological Disorder Treatments

Brainstorm Cell Therapeutics Inc. provided an update on the grant and allowance of three patent applications for NurOwn® and NurOwn-Exosomes. The patent grants claims for an isolated population of mesenchymal stem cells for use in treating amyotrophic lateral sclerosis.